N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide
C29H26BrFN4O3S — CID 166345516
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide
N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide (PubChem CID 166345516) has the molecular formula C29H26BrFN4O3S and a molecular weight of 609.52 g/mol. Its IUPAC name is N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide.
Molecular Properties
| Compound Name | N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide |
|---|---|
| PubChem CID | 166345516 |
| Molecular Formula | C29H26BrFN4O3S |
| Molecular Weight | 609.52 g/mol |
| Exact Mass | 608.09 |
| IUPAC Name | N-(2-bromo-5-methylphenyl)-3-[4-[4-(3-fluorophenyl)pyrimidin-2-yl]piperidine-1-carbonyl]benzenesulfonamide |
| SMILES | Cc1ccc(Br)c(NS(=O)(=O)c2cccc(C(=O)N3CCC(c4nccc(-c5cccc(F)c5)n4)CC3)c2)c1 |
| InChI | InChI=1S/C29H26BrFN4O3S/c1-19-8-9-25(30)27(16-19)34-39(37,38)24-7-3-5-22(18-24)29(36)35-14-11-20(12-15-35)28-32-13-10-26(33-28)21-4-2-6-23(31)17-21/h2-10,13,16-18,20,34H,11-12,14-15H2,1H3 |
| InChIKey | RPVOSJCQZIXJCT-UHFFFAOYSA-N |
| XLogP | 6.17 |
| TPSA | 92.26 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 609.52 |
| LogP ≤ 5 | 6.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166345516 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.